Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?

Am J Respir Crit Care Med. 2017 Jan 15;195(2):269-270. doi: 10.1164/rccm.201605-1074LE.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Diphosphonates*
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Pulmonary Fibrosis
  • Vitamin K

Substances

  • Anticoagulants
  • Diphosphonates
  • Vitamin K